These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
646 related articles for article (PubMed ID: 25661032)
21. New antiarrhythmic targets in atrial fibrillation. Voigt N; Heijman J; Dobrev D Future Cardiol; 2015; 11(6):645-54. PubMed ID: 26609872 [TBL] [Abstract][Full Text] [Related]
22. Atrial myofibroblast activation and connective tissue formation in a porcine model of atrial fibrillation and reduced left ventricular function. Lugenbiel P; Wenz F; Govorov K; Syren P; Katus HA; Thomas D Life Sci; 2017 Jul; 181():1-8. PubMed ID: 28546006 [TBL] [Abstract][Full Text] [Related]
23. [Biology of the substrate of atrial fibrillation]. Hatem S Biol Aujourdhui; 2012; 206(1):5-9. PubMed ID: 22463991 [TBL] [Abstract][Full Text] [Related]
24. Perspectives and challenges of antioxidant therapy for atrial fibrillation. Gasparova I; Kubatka P; Opatrilova R; Caprnda M; Filipova S; Rodrigo L; Malan L; Mozos I; Rabajdova M; Nosal V; Kobyliak N; Valentova V; Petrovic D; Adamek M; Kruzliak P Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):1-14. PubMed ID: 27900409 [TBL] [Abstract][Full Text] [Related]
25. Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis. Violi F; Pastori D; Pignatelli P; Loffredo L Europace; 2014 Aug; 16(8):1107-16. PubMed ID: 24706090 [TBL] [Abstract][Full Text] [Related]
26. Synergistic Effects of Weight Loss and Catheter Ablation: Can microRNAs Serve as Predictive Biomarkers for the Prevention of Atrial Fibrillation Recurrence? Förster CY; Künzel SR; Shityakov S; Stavrakis S Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731908 [TBL] [Abstract][Full Text] [Related]
27. The impact of cryoballoon-based catheter ablation on left atrial structural and potential electrical remodeling in patients with paroxysmal atrial fibrillation. Canpolat U; Aytemir K; Özer N; Oto A J Interv Card Electrophysiol; 2015 Nov; 44(2):131-9. PubMed ID: 26238480 [TBL] [Abstract][Full Text] [Related]
28. Data Linking Diabetes Mellitus and Atrial Fibrillation-How Strong Is the Evidence? From Epidemiology and Pathophysiology to Therapeutic Implications. Şerban RC; Scridon A Can J Cardiol; 2018 Nov; 34(11):1492-1502. PubMed ID: 30404752 [TBL] [Abstract][Full Text] [Related]
30. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits. Fu H; Li G; Liu C; Li J; Wang X; Cheng L; Liu T J Cardiovasc Electrophysiol; 2015 Feb; 26(2):211-22. PubMed ID: 25199622 [TBL] [Abstract][Full Text] [Related]
31. Left atrial appendage flow velocity and time from P-wave onset to tissue Doppler-derived A' predict atrial fibrillation recurrence after radiofrequency catheter ablation. Fukushima K; Fukushima N; Ejima K; Kato K; Sato Y; Uematsu S; Arai K; Manaka T; Takagi A; Ashihara K; Shoda M; Hagiwara N Echocardiography; 2015 Jul; 32(7):1101-8. PubMed ID: 25362992 [TBL] [Abstract][Full Text] [Related]
32. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Korantzopoulos P; Kolettis TM; Galaris D; Goudevenos JA Int J Cardiol; 2007 Feb; 115(2):135-43. PubMed ID: 16764958 [TBL] [Abstract][Full Text] [Related]
33. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. Marrouche NF; Wilber D; Hindricks G; Jais P; Akoum N; Marchlinski F; Kholmovski E; Burgon N; Hu N; Mont L; Deneke T; Duytschaever M; Neumann T; Mansour M; Mahnkopf C; Herweg B; Daoud E; Wissner E; Bansmann P; Brachmann J JAMA; 2014 Feb; 311(5):498-506. PubMed ID: 24496537 [TBL] [Abstract][Full Text] [Related]
34. Electrophysiological characteristics of permanent atrial fibrillation: insights from research models of cardiac remodeling. Climent AM; Guillem MS; Atienza F; Fernández-Avilés F Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):1-3. PubMed ID: 25434351 [TBL] [Abstract][Full Text] [Related]
35. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Schotten U; Verheule S; Kirchhof P; Goette A Physiol Rev; 2011 Jan; 91(1):265-325. PubMed ID: 21248168 [TBL] [Abstract][Full Text] [Related]
36. Impact of metabolic syndrome on left atrial electroanatomical remodeling and outcomes after radiofrequency ablation of nonvalvular atrial fibrillation. Dinov B; Kosiuk J; Kircher S; Bollmann A; Acou WJ; Arya A; Hindricks G; Rolf S Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):483-9. PubMed ID: 24833645 [TBL] [Abstract][Full Text] [Related]
37. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion. Kang JH; Lee DI; Kim S; Kim MN; Park YM; Ban JE; Choi JI; Lim HE; Park SW; Kim YH J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1165-70. PubMed ID: 22882453 [TBL] [Abstract][Full Text] [Related]
38. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. Nattel S; Harada M J Am Coll Cardiol; 2014 Jun; 63(22):2335-45. PubMed ID: 24613319 [TBL] [Abstract][Full Text] [Related]
39. The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling. Yalcin MU; Gurses KM; Kocyigit D; Canpinar H; Canpolat U; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Tokgozoglu L; Oto MA; Ozer N; Guc D; Aytemir K J Cardiovasc Electrophysiol; 2015 Jun; 26(6):635-40. PubMed ID: 25684038 [TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation. Ling LH; McLellan AJ; Taylor AJ; Iles LM; Ellims AH; Kumar S; Teh A; Lee G; Wong MC; Azzopardi S; Sellenger MA; Morton JB; Kalman JM; Kistler PM Heart Rhythm; 2014 Sep; 11(9):1551-9. PubMed ID: 24931636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]